# A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

> **NCT00568412** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 80 (actual)

## Conditions studied

- Mild to Moderate Atopic Dermatitis

## Interventions

- **DEVICE:** Zarzenda
- **DRUG:** Elidel

## Key facts

- **NCT ID:** NCT00568412
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00568412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00568412, "A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00568412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*